It actually has European Medicines Agency
approval, which it received almost simultaneously with FDA
approval. However, as you say, this Reuters piece indicates delays in its actual release in Europe.
Though they didn't make it clear what the estimates were based on, the MS Ireland newsletter stated that it should be available for patients in Ireland in late 2014 (c. 18 months).